Cargando…

The 2023 Impact of Inflammatory Bowel Disease in Canada: Executive Summary

The burden of inflammatory bowel disease (IBD) (i.e., associated direct and indirect costs, prevalence of disease, personal impact to the individual and to caregivers) continues to increase in Canada. The prevalence of IBD has increased since Crohn’s and Colitis Canada’s 2018 Impact of IBD report fr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Windsor, Joseph W, Kuenzig, M Ellen, Murthy, Sanjay K, Bitton, Alain, Bernstein, Charles N, Jones, Jennifer L, Lee, Kate, Targownik, Laura E, Peña-Sánchez, Juan-Nicolás, Rohatinsky, Noelle, Ghandeharian, Sara, Im, James H B, Davis, Tal, Weinstein, Jake, Goddard, Quinn, Gorospe, Julia, Benchimol, Eric I, Kaplan, Gilaad G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Supplement Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478799/ https://www.ncbi.nlm.nih.gov/pubmed/37674500 http://dx.doi.org/10.1093/jcag/gwad003

Ejemplares similares

The 2023 Impact of Inflammatory Bowel Disease in Canada: Epidemiology of IBD
por: Coward, Stephanie, et al.
Publicado: (2023)

The 2023 Impact of Inflammatory Bowel Disease in Canada: Special Populations—IBD in Seniors
por: Shaffer, Seth R, et al.
Publicado: (2023)

The 2023 Impact of Inflammatory Bowel Disease in Canada: Cancer and IBD
por: Murthy, Sanjay K, et al.
Publicado: (2023)

The 2023 Impact of Inflammatory Bowel Disease in Canada: Indirect (Individual and Societal) and Direct Out-of-Pocket Costs
por: Kuenzig, M Ellen, et al.
Publicado: (2023)

The 2023 Impact of Inflammatory Bowel Disease in Canada: COVID-19 and IBD
por: Kaplan, Gilaad G, et al.
Publicado: (2023)

The 2023 Impact of Inflammatory Bowel Disease in Canada: Mental Health and Inflammatory Bowel Disease
por: Graff, Lesley A, et al.
Publicado: (2023)

The 2023 Impact of Inflammatory Bowel Disease in Canada: Access to and Models of Care
por: Mathias, Holly, et al.
Publicado: (2023)

The 2023 Impact of Inflammatory Bowel Disease in Canada: Special Populations—Children and Adolescents with IBD
por: El-Matary, Wael, et al.
Publicado: (2023)

The 2023 Impact of Inflammatory Bowel Disease in Canada: Treatment Landscape
por: Murthy, Sanjay K, et al.
Publicado: (2023)

The 2023 Impact of Inflammatory Bowel Disease in Canada: Direct Health System and Medication Costs
por: Kuenzig, M Ellen, et al.
Publicado: (2023)

The 2023 Impact of Inflammatory Bowel Disease in Canada: The Influence of Sex and Gender on Canadians Living With Inflammatory Bowel Disease
por: Targownik, Laura E, et al.
Publicado: (2023)

Costs of missed work among employed people with inflammatory bowel disease: a cross-sectional population-representative study.
por: Kuenzig, Ellen, et al.
Publicado: (2022)

Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Executive Summary
por: Ellen Kuenzig, M, et al.
Publicado: (2021)

Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Epidemiology—The Trends of Disease Over Time
por: Coward, Stephanie, et al.
Publicado: (2021)

Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Health Care Delivery During the Pandemic and the Future Model of Inflammatory Bowel Disease Care
por: Jones, Jennifer L, et al.
Publicado: (2021)

The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization
por: Kuenzig, M Ellen, et al.
Publicado: (2019)

Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Risk Factors and Medications
por: Targownik, Laura E, et al.
Publicado: (2021)

Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Seniors With IBD
por: Bernstein, Charles N, et al.
Publicado: (2021)

Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Mental Health and Quality of Life
por: Graff, Lesley A, et al.
Publicado: (2021)

The Impact of Inflammatory Bowel Disease in Canada 2018: IBD in Seniors
por: Nguyen, Geoffrey C, et al.
Publicado: (2019)

A220 ONTARIO POPULATION TRENDS IN INTESTINAL AND EXTRA-INTESTINAL CANCERS OVER 25 YEARS AMONG PERSONS WITH INFLAMMATORY BOWEL DISEASES AND MATCHED CONTROLS
por: Murthy, S K, et al.
Publicado: (2023)

Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: COVID-19 Vaccines—Biology, Current Evidence and Recommendations
por: Murthy, Sanjay K, et al.
Publicado: (2021)

Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Children and Expectant Mothers With Inflammatory Bowel Disease
por: Benchimol, Eric I, et al.
Publicado: (2021)

A169 THE DIRECT COSTS OF INFLAMMATORY BOWEL DISEASE IN CANADA: A POPULATION-BASED ANALYSIS OF HISTORICAL AND CURRENT COSTS
por: Coward, S, et al.
Publicado: (2023)

A210 THE BURDEN OF IBD HOSPITALIZATION IN CANADA: AN ASSESSMENT OF THE CURRENT AND FUTURE BURDEN IN A NATION-WIDE ANALYSIS
por: Coward, S, et al.
Publicado: (2023)

A35 FORECASTING THE INCIDENCE AND PREVALENCE OF INFLAMMATORY BOWEL DISEASE: A CANADIAN NATION-WIDE ANALYSIS
por: Coward, S, et al.
Publicado: (2023)

The Impact of Inflammatory Bowel Disease in Canada 2018: Indirect Costs of IBD Care
por: Kuenzig, M Ellen, et al.
Publicado: (2019)

Introduction of anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases: a population-based interrupted time series study
por: Murthy, Sanjay K, et al.
Publicado: (2020)

A168 COSTS OF MISSED WORK AMONG PEOPLE WITH INFLAMMATORY BOWEL DISEASE: A CROSS-SECTIONAL POPULATION-REPRESENTATIVE STUDY
por: Kuenzig, E, et al.
Publicado: (2023)

The Impact of Inflammatory Bowel Disease in Canada 2018: Extra-intestinal Diseases in IBD
por: Bernstein, Charles N, et al.
Publicado: (2019)

GOLD 2023 Executive Summary: responses from the GOLD Scientific Committee
por: Agustí, Alvar, et al.
Publicado: (2023)

Co-occurrence of Asthma and the Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis
por: Kuenzig, M. Ellen, et al.
Publicado: (2018)

Uptake of third doses of SARS-CoV-2 vaccines among people with inflammatory bowel disease in Ontario, Canada
por: Kuenzig, M Ellen, et al.
Publicado: (2022)

A188 INFORMING IMMUNOCOMPROMISED POPULATIONS: AN EFFECTIVE AND EFFICIENT COVID-19 KNOWLEDGE TRANSLATION STRATEGY
por: Windsor, J W, et al.
Publicado: (2023)

Variation in care of patients with elderly-onset inflammatory bowel disease in Ontario, Canada: A population-based cohort study
por: Kuenzig, M Ellen, et al.
Publicado: (2020)

The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD
por: Carroll, Matthew W, et al.
Publicado: (2019)

The Impact of Inflammatory Bowel Disease in Canada 2018: Epidemiology
por: Kaplan, Gilaad G, et al.
Publicado: (2019)

The Impact of Inflammatory Bowel Disease in Canada 2018: A Scientific Report from the Canadian Gastro-Intestinal Epidemiology Consortium to Crohn’s and Colitis Canada
por: Benchimol, Eric I, et al.
Publicado: (2019)

Shifting Health Care Use from Hospitalisations and Surgeries to Outpatient Visits in Children with Inflammatory Bowel Disease: A Population-based Cohort Study from Ontario, Canada
por: Dheri, Aman K, et al.
Publicado: (2021)

Hospitalization Rates for Inflammatory Bowel Disease Are Decreasing Over Time: A Population-based Cohort Study
por: Buie, Michael J, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1fr4hulje15ei1kil4btnbor75